Questcor

With $135M rights deal, Questcor locks up rival to its pricey Acthar drug

With $135M rights deal, Questcor locks up rival to its pricey Acthar drug

Fierce Pharma

Questcor Surges on Drug Acquisition

Questcor Surges on Drug Acquisition

Yahoo/Zacks

Questcor Surges After Acquiring Rights to Novartis Drug

Questcor Surges After Acquiring Rights to Novartis Drug

Bloomberg

The Market's Got This Biotech All Wrong

The Market's Got This Biotech All Wrong

Motley Fool

Questcor Pharmaceuticals In Play Ahead Of Earnings Release

Questcor Pharmaceuticals In Play Ahead Of Earnings Release

Seeking Alpha

The 3 Drivers Behind The Big Pharma Rally

The 3 Drivers Behind The Big Pharma Rally

Seeking Alpha

3 Big Concerns for the Pharmaceutical Industry

3 Big Concerns for the Pharmaceutical Industry

Motley Fool

The Best- And Worst-Performing Biotech Stocks In February

The Best- And Worst-Performing Biotech Stocks In February

Forbes

Solid Where It Matters: Questcor To Climb On Strong Quarter And Dividend Raise

Solid Where It Matters: Questcor To Climb On Strong Quarter And Dividend Raise

Seeking Alpha

5 Can't-Miss Health-Care Events This Week

5 Can't-Miss Health-Care Events This Week

Motley Fool